ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 77 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $206,000 | -17.3% | 121 | 0.0% | 0.00% | – |
| Q1 2022 | $249,000 | -45.2% | 121 | 0.0% | 0.00% | – |
| Q4 2021 | $454,000 | -27.5% | 121 | 0.0% | 0.00% | – |
| Q3 2021 | $626,000 | +33.8% | 121 | 0.0% | 0.00% | – |
| Q2 2021 | $468,000 | -27.1% | 121 | 0.0% | 0.00% | – |
| Q1 2021 | $642,000 | -1.5% | 121 | 0.0% | 0.00% | – |
| Q4 2020 | $652,000 | -32.5% | 121 | 0.0% | 0.00% | – |
| Q3 2020 | $966,000 | -20.2% | 121 | 0.0% | 0.00% | – |
| Q2 2020 | $1,211,000 | +268.1% | 121 | 0.0% | 0.00% | – |
| Q1 2020 | $329,000 | -38.7% | 121 | 0.0% | 0.00% | – |
| Q4 2019 | $537,000 | +193.4% | 121 | 0.0% | 0.00% | – |
| Q3 2019 | $183,000 | -62.3% | 121 | 0.0% | 0.00% | – |
| Q2 2019 | $486,000 | -6.5% | 121 | 0.0% | 0.00% | – |
| Q1 2019 | $520,000 | -25.3% | 121 | 0.0% | 0.00% | – |
| Q4 2018 | $696,000 | -56.8% | 121 | 0.0% | 0.00% | – |
| Q3 2018 | $1,612,000 | -99.0% | 121 | -99.1% | 0.00% | -100.0% |
| Q2 2018 | $160,274,000 | +18.8% | 13,372 | 0.0% | 0.03% | 0.0% |
| Q1 2018 | $134,863,000 | – | 13,372 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |